These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 25690018)

  • 1. Pharmacogenetics and breast cancer management: current status and perspectives.
    Ciccolini J; Fanciullino R; Serdjebi C; Milano G
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):719-29. PubMed ID: 25690018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside analogs: ready to enter the era of precision medicine?
    Ciccolini J; Serdjebi C; Le Thi Thu H; Lacarelle B; Milano G; Fanciullino R
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):865-77. PubMed ID: 27218825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic Predictors of Response.
    Hertz DL; Rae JM
    Adv Exp Med Biol; 2016; 882():191-215. PubMed ID: 26987536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Medicine and Targeted Therapies in Breast Cancer.
    Greenwalt I; Zaza N; Das S; Li BD
    Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized medicine in oncology: where have we come from and where are we going?
    André F; Ciccolini J; Spano JP; Penault-Llorca F; Mounier N; Freyer G; Blay JY; Milano G
    Pharmacogenomics; 2013 Jun; 14(8):931-9. PubMed ID: 23746187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.
    Marsh S; Liu G
    Adv Drug Deliv Rev; 2009 May; 61(5):381-7. PubMed ID: 19100797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing breast cancer treatment through pharmacogenomics: A narrative review.
    Kumar RMR; Joghee S
    Clin Chim Acta; 2024 Aug; 562():119893. PubMed ID: 39068964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
    Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
    Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of variants in ATP-binding cassette transporters on breast cancer treatment.
    Xiao Q; Zhou Y; Lauschke VM
    Pharmacogenomics; 2020 Dec; 21(18):1299-1310. PubMed ID: 33222659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer.
    Wang B; Rosano JM; Cheheltani R; Achary MP; Kiani MF
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1159-73. PubMed ID: 20738211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas.
    Shai RM; Reichardt JK; Chen TC
    Future Oncol; 2008 Aug; 4(4):525-34. PubMed ID: 18684063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab.
    Longo R; D'Andrea M; Sarmiento R; Gasparini G
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S41-50. PubMed ID: 20374029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in breast cancer: current trends and future directions.
    Wajapeyee N; Somasundaram K
    Curr Opin Mol Ther; 2004 Jun; 6(3):296-301. PubMed ID: 15264432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics and breast cancer.
    Lymberis SC; Parhar PK; Katsoulakis E; Formenti SC
    Pharmacogenomics; 2004 Jan; 5(1):31-55. PubMed ID: 14683419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
    Hattinger CM; Serra M
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1449-63. PubMed ID: 26095223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approach.
    Iyer PM; Karthikeyan S; Sanjay Kumar P; Krishnan Namboori PK
    Funct Integr Genomics; 2017 Jul; 17(4):375-385. PubMed ID: 28470340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic pharmacogenomics in cancer.
    Ikediobi ON
    Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.